Event
14th International Congress on Myeloproliferative Neoplasms
presented by International Congress on Myeloproliferative Neoplasms
1 other would like to attend.
Register Now
Thursday, October 27, 2022 7 AM
-
Friday, October 28, 2022
3 PM
America/New_York
Add to Calendar
333 Adams Street, Brooklyn, NY 11201
Event info
OVERVIEW
With great pleasure, we invite you to attend the 14th International Congress on Myeloproliferative Neoplasms (MPN Congress), scheduled for October 27-28, 2022 at the New York Marriott-Brooklyn Bridge in Brooklyn, New York.
Established more than 20 years ago, the MPN Congress provides a unique forum for the exchange of timely and relevant information about the pathogenesis, diagnosis and treatment of MPNs for attendees from around the world. The Congress will continue to emphasize faculty interaction, audience participation and personal interaction between the teaching faculty and attendees, all of which have contributed to the meeting’s success over the years.
This year’s two-day program will include presentations from more than 20 world-renowned experts covering the latest scientific, clinical and therapeutic developments in the rapidly evolving MPN field. Additionally, we are pleased to introduce a new session this year featuring challenging MPN case presentations with interactive audience participation. We hope that you will take the opportunity to attend this premier educational meeting dedicated to advancing the treatment of MPNs and improving patient outcomes.
TARGET AUDIENCE
This educational activity is intended for hematologists, medical oncologists, translational scientists, and other healthcare professionals (physicians, clinicians, physicians-in-training, oncology nurses, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with myeloproliferative neoplasms and related disorders.
LEARNING OBJECTIVES
Upon completion of this educational activity, participants should be able to:
- Understand the molecular pathogenesis of myeloproliferative neoplasms (MPNs) and related disorders.
- Discuss the role and utilization of current approved therapies in MPNs, including the recent advances in therapeutics.
- Describe the potential role of agents in development for MPNs.
- Assess how to manage symptoms and therapy-associated adverse events for patients with MPNs.
ACCREDITATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Medical and Nursing Education, Inc. and Melton Medical Education, LLC . The Institute for Medical and Nursing Education, Inc. is accredited by the ACCME to provide continuing medical education for physicians
IMNE designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
For more information please visit the official event page.
Faculty
-
Richard T. SilverChairman
-
Jerry L. SpivakCo-Chairman
Course Syllabus
Click HERE to view the syllabus
1 other would like to attend.
Register Now